Literature DB >> 24408909

A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.

Petra Van Damme1, Svein I Støve2, Nina Glomnes3, Kris Gevaert4, Thomas Arnesen5.   

Abstract

N-terminal acetylation (Nt-acetylation) occurs on the majority of eukaryotic proteins and is catalyzed by N-terminal acetyltransferases (NATs). Nt-acetylation is increasingly recognized as a vital modification with functional implications ranging from protein degradation to protein localization. Although early genetic studies in yeast demonstrated that NAT-deletion strains displayed a variety of phenotypes, only recently, the first human genetic disorder caused by a mutation in a NAT gene was reported; boys diagnosed with the X-linked Ogden syndrome harbor a p.Ser37Pro (S37P) mutation in the gene encoding Naa10, the catalytic subunit of the NatA complex, and suffer from global developmental delays and lethality during infancy. Here, we describe a Saccharomyces cerevisiae model developed by introducing the human wild-type or mutant NatA complex into yeast lacking NatA (NatA-Δ). The wild-type human NatA complex phenotypically complemented the NatA-Δ strain, whereas only a partial rescue was observed for the Ogden mutant NatA complex suggesting that hNaa10 S37P is only partially functional in vivo. Immunoprecipitation experiments revealed a reduced subunit complexation for the mutant hNatA S37P next to a reduced in vitro catalytic activity. We performed quantitative Nt-acetylome analyses on a control yeast strain (yNatA), a yeast NatA deletion strain (yNatA-Δ), a yeast NatA deletion strain expressing wild-type human NatA (hNatA), and a yeast NatA deletion strain expressing mutant human NatA (hNatA S37P). Interestingly, a generally reduced degree of Nt-acetylation was observed among a large group of NatA substrates in the yeast expressing mutant hNatA as compared with yeast expressing wild-type hNatA. Combined, these data provide strong support for the functional impairment of hNaa10 S37P in vivo and suggest that reduced Nt-acetylation of one or more target substrates contributes to the pathogenesis of the Ogden syndrome. Comparative analysis between human and yeast NatA also provided new insights into the co-evolution of the NatA complexes and their substrates. For instance, (Met-)Ala- N termini are more prevalent in the human proteome as compared with the yeast proteome, and hNatA displays a preference toward these N termini as compared with yNatA.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24408909      PMCID: PMC4125735          DOI: 10.1074/mcp.M113.035402

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  63 in total

1.  Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae.

Authors:  B Polevoda; J Norbeck; H Takakura; A Blomberg; F Sherman
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

2.  Acetylation of Protein N-terminal amino groups structural observations on alpha-amino acetylated proteins.

Authors:  H Jörnvall
Journal:  J Theor Biol       Date:  1975-11       Impact factor: 2.691

3.  ms_lims, a simple yet powerful open source laboratory information management system for MS-driven proteomics.

Authors:  Kenny Helsens; Niklaas Colaert; Harald Barsnes; Thilo Muth; Kristian Flikka; An Staes; Evy Timmerman; Steffi Wortelkamp; Albert Sickmann; Joël Vandekerckhove; Kris Gevaert; Lennart Martens
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

4.  Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans.

Authors:  B Sönnichsen; L B Koski; A Walsh; P Marschall; B Neumann; M Brehm; A-M Alleaume; J Artelt; P Bettencourt; E Cassin; M Hewitson; C Holz; M Khan; S Lazik; C Martin; B Nitzsche; M Ruer; J Stamford; M Winzi; R Heinkel; M Röder; J Finell; H Häntsch; S J M Jones; M Jones; F Piano; K C Gunsalus; K Oegema; P Gönczy; A Coulson; A A Hyman; C J Echeverri
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

5.  Drosophila variable nurse cells encodes arrest defective 1 (ARD1), the catalytic subunit of the major N-terminal acetyltransferase complex.

Authors:  Ying Wang; Michelle Mijares; Megan D Gall; Tolga Turan; Anna Javier; Douglas J Bornemann; Kevin Manage; Rahul Warrior
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

6.  Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.

Authors:  Ji-Hong Lim; Jong-Wan Park; Yang-Sook Chun
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

7.  Analysis of ARD1 function in hypoxia response using retroviral RNA interference.

Authors:  Tim S Fisher; Shelley Des Etages; Lisa Hayes; Kim Crimin; Baiyong Li
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

8.  The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways.

Authors:  M Whiteway; J W Szostak
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

9.  Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway.

Authors:  Anna Shemorry; Cheol-Sang Hwang; Alexander Varshavsky
Journal:  Mol Cell       Date:  2013-04-18       Impact factor: 17.970

10.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

View more
  23 in total

1.  Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.

Authors:  Hanyin Cheng; Avinash V Dharmadhikari; Sylvia Varland; Ning Ma; Deepti Domingo; Robert Kleyner; Alan F Rope; Margaret Yoon; Asbjørg Stray-Pedersen; Jennifer E Posey; Sarah R Crews; Mohammad K Eldomery; Zeynep Coban Akdemir; Andrea M Lewis; Vernon R Sutton; Jill A Rosenfeld; Erin Conboy; Katherine Agre; Fan Xia; Magdalena Walkiewicz; Mauro Longoni; Frances A High; Marjon A van Slegtenhorst; Grazia M S Mancini; Candice R Finnila; Arie van Haeringen; Nicolette den Hollander; Claudia Ruivenkamp; Sakkubai Naidu; Sonal Mahida; Elizabeth E Palmer; Lucinda Murray; Derek Lim; Parul Jayakar; Michael J Parker; Stefania Giusto; Emanuela Stracuzzi; Corrado Romano; Jennifer S Beighley; Raphael A Bernier; Sébastien Küry; Mathilde Nizon; Mark A Corbett; Marie Shaw; Alison Gardner; Christopher Barnett; Ruth Armstrong; Karin S Kassahn; Anke Van Dijck; Geert Vandeweyer; Tjitske Kleefstra; Jolanda Schieving; Marjolijn J Jongmans; Bert B A de Vries; Rolph Pfundt; Bronwyn Kerr; Samantha K Rojas; Kym M Boycott; Richard Person; Rebecca Willaert; Evan E Eichler; R Frank Kooy; Yaping Yang; Joseph C Wu; James R Lupski; Thomas Arnesen; Gregory M Cooper; Wendy K Chung; Jozef Gecz; Holly A F Stessman; Linyan Meng; Gholson J Lyon
Journal:  Am J Hum Genet       Date:  2018-04-12       Impact factor: 11.025

Review 2.  The biological functions of Naa10 - From amino-terminal acetylation to human disease.

Authors:  Max J Dörfel; Gholson J Lyon
Journal:  Gene       Date:  2015-05-16       Impact factor: 3.688

3.  A Strong Cation Exchange Chromatography Protocol for Examining N-Terminal Proteoforms.

Authors:  Esperanza Fernández; Annelies Bogaert; Evy Timmerman; An Staes; Francis Impens; Kris Gevaert
Journal:  Methods Mol Biol       Date:  2022

4.  Structure of Human NatA and Its Regulation by the Huntingtin Interacting Protein HYPK.

Authors:  Leah Gottlieb; Ronen Marmorstein
Journal:  Structure       Date:  2018-05-10       Impact factor: 5.006

5.  N-terminal acetylation and methylation differentially affect the function of MYL9.

Authors:  Chris Nevitt; John G Tooley; Christine E Schaner Tooley
Journal:  Biochem J       Date:  2018-10-22       Impact factor: 3.857

6.  A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.

Authors:  Svein Isungset Støve; Marina Blenski; Asbjørg Stray-Pedersen; Klaas J Wierenga; Shalini N Jhangiani; Zeynep Coban Akdemir; David Crawford; Nina McTiernan; Line M Myklebust; Gabriela Purcarin; Rene McNall-Knapp; Alexandrea Wadley; John W Belmont; Jeffrey J Kim; James R Lupski; Thomas Arnesen
Journal:  Eur J Hum Genet       Date:  2018-05-10       Impact factor: 4.246

7.  Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.

Authors:  Hanyin Cheng; Leah Gottlieb; Elaine Marchi; Robert Kleyner; Puja Bhardwaj; Alan F Rope; Sarah Rosenheck; Sébastien Moutton; Christophe Philippe; Wafaa Eyaid; Fowzan S Alkuraya; Janet Toribio; Rafael Mena; Carlos E Prada; Holly Stessman; Raphael Bernier; Marieke Wermuth; Birgit Kauffmann; Bettina Blaumeiser; R Frank Kooy; Diana Baralle; Grazia M S Mancini; Simon J Conway; Fan Xia; Zhao Chen; Linyan Meng; Ljubisa Mihajlovic; Ronen Marmorstein; Gholson J Lyon
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

8.  Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway.

Authors:  Hyae Yon Kweon; Mi-Ni Lee; Max Dorfel; Seungwoon Seo; Leah Gottlieb; Thomas PaPazyan; Nina McTiernan; Rasmus Ree; David Bolton; Andrew Garcia; Michael Flory; Jonathan Crain; Alison Sebold; Scott Lyons; Ahmed Ismail; Elaine Marchi; Seong-Keun Sonn; Se-Jin Jeong; Sejin Jeon; Shinyeong Ju; Simon J Conway; Taesoo Kim; Hyun-Seok Kim; Cheolju Lee; Tae-Young Roh; Thomas Arnesen; Ronen Marmorstein; Goo Taeg Oh; Gholson J Lyon
Journal:  Elife       Date:  2021-08-06       Impact factor: 8.713

9.  Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects.

Authors:  Line M Myklebust; Petra Van Damme; Svein I Støve; Max J Dörfel; Angèle Abboud; Thomas V Kalvik; Cedric Grauffel; Veronique Jonckheere; Yiyang Wu; Jeffrey Swensen; Hanna Kaasa; Glen Liszczak; Ronen Marmorstein; Nathalie Reuter; Gholson J Lyon; Kris Gevaert; Thomas Arnesen
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

10.  De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.

Authors:  Bernt Popp; Svein I Støve; Sabine Endele; Line M Myklebust; Juliane Hoyer; Heinrich Sticht; Silvia Azzarello-Burri; Anita Rauch; Thomas Arnesen; André Reis
Journal:  Eur J Hum Genet       Date:  2014-08-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.